Dana-Farber, Brigham and Women's Start Tumor Genotyping Collaboration | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Dana-Farber Cancer Institute and Brigham and Women's Hospital have launched a genotyping project that will study tumor tissue in a search for cancer related gene mutations.

The project, called Profile, will be open to every adult cancer patient at the Brigham and Women's and Dana-Farber Longwood Medical Area clinics, and in the coming year it will be extended to pediatric cancer patients, Dana-Farber said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.